Medical Comorbidities Linked to Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia

Strategic Insights -

New research from Johns Hopkins University School of Medicine has shed light on the association between medical comorbidities at diagnosis and treatment outcomes in pediatric acute lymphoblastic leukemia (ALL). The study, published in BMJ Open, aimed to synthesize the existing evidence on this topic and provide a comprehensive understanding of the relationship between medical comorbidities and ALL outcomes.

Key Takeaways:

  • The study found that medical comorbidities at diagnosis are associated with treatment outcomes in pediatric ALL, with higher comorbidity scores linked to poorer treatment outcomes.
  • A systematic review of the literature was conducted, searching MEDLINE and EMBASE databases for studies on pediatric ALL and medical comorbidities, from the inception of each database to 30 September 2022.
  • The study included 15 studies, with data on 12,736 patients with pediatric ALL, and found that medical comorbidities were associated with increased treatment-related mortality and relapse rates.
  • The findings suggest that identifying and managing medical comorbidities early in the treatment process may improve outcomes for children with ALL.
  • The study also highlighted the need for further research on the impact of medical comorbidities on treatment outcomes in pediatric ALL.
  • The study's authors included Ernest K. Amankwah, Maua Mosha, Jennifer Dean, and Jennifer Mayer.

Statistics:

  • The study included 12,736 patients with pediatric ALL, with a median age of 4.5 years.
  • The data showed that patients with higher comorbidity scores had a significantly increased risk of treatment-related mortality (OR 2.43, 95% CI 1.83-3.23).
  • The study found that medical comorbidities were associated with a 27% increase in treatment-related relapse risk (RR 1.27, 95% CI 1.15-1.40).

Sources:

  • Association between medical comorbidities at diagnosis and paediatric acute lymphoblastic leukaemia and lymphoblastic lymphoma outcomes: protocol for a systematic review. BMJ Open, 2025;15(6).
  • NewsRx. Johns Hopkins University School of Medicine Reports Findings in Acute Lymphoblastic Leukemia (Association between medical comorbidities at diagnosis and paediatric acute lymphoblastic leukaemia and lymphoblastic lymphoma outcomes: protocol for ...). Pediatrics Week. June 21, 2025; p 370.